Loading…
Arthritis Innovation Corporation is a biotechnology company developing non-opioid, long-acting injectable therapies for post-surgical recovery. Its primary product, F14, is an intra-articular anti-inflammatory designed to improve pain management and functional recovery for patients following total knee replacement surgery.
AI named Arthritis Innovation Corporation in September 2026.
AI named Arthritis Innovation Corporation alongside Smithsonian American Art Museum and Hirshhorn Museum and Sculpture Garden.
None of these answers cited aic.com. AI leaned on repository.si.edu, americanart.si.edu, and hirshhorn.si.edu.
aic.com 0%Other sites 100%
